Serial 97295474
Live / Registered — Registered (as of 16 Jan 2024)
What this means for you
Registered since 16 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97295474
- Registration number
- 7280318
- Mark type
- Design / logo
- Filed
- 04 Mar 2022
- Published for opposition
- 24 Jan 2023
- Registered
- 16 Jan 2024
- Attorney of record
- Christopher Nichols
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, biological and chemical preparations for the prevention and treatment of cancer and infectious diseases
- Class 042 — Scientific and technological services: Research and development in the fields of pharmaceutical, biotechnology, and therapeutics; Research and development of vaccines; scientific study and research in the fields of disease, biochemistry, biology, and/or pharmaceuticals; laboratory research in the field of biology or biochemistry; pharmaceutical drug research and development; pharmaceutical drug discovery and development services; medical research services; medical research services in the field of cancer
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases
Owner
- Immunomic Therapeutics, Inc., Rockville, MD, US
- Immunomic Therapeutics, Inc., Rockville, MD, US
- Immunomic Therapeutics, Inc., Rockville, MD, US
Prosecution history
- 17 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Nov 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Nov 2023 — NON-FINAL ACTION E-MAILED
- 16 Nov 2023 — SU - NON-FINAL ACTION - WRITTEN
- 03 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Sept 2023 — USE AMENDMENT FILED
- 02 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED